Literature DB >> 27507774

The costs and benefits of brain dopamine for cognitive control.

Roshan Cools1.   

Abstract

Cognitive control helps us attain our goals by resisting distraction and temptations. Dopaminergic drugs are well known to enhance cognitive control. However, there is great variability in the effects of dopaminergic drugs across different contexts, with beneficial effects on some tasks but detrimental effects on other tasks. The mechanisms underlying this variability across cognitive task demands remain unclear. I aim to elucidate this across-task variability in dopaminergic drug efficacy by going beyond classic models that emphasize the importance of dopamine in the prefrontal cortex for cognitive control and working memory. To this end, I build on recent advances in cognitive neuroscience that highlight a role for dopamine in cost-benefit decision making. Specifically, I reconceptualize cognitive control as involving not just prefrontal dopamine but also modulation of cost-benefit decision making by striatal dopamine. This approach will help us understand why we sometimes fail to (choose to) exert cognitive control while also identifying mechanistic factors that predict dopaminergic drug effects on cognitive control. WIREs Cogn Sci 2016, 7:317-329. doi: 10.1002/wcs.1401 For further resources related to this article, please visit the WIREs website.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27507774     DOI: 10.1002/wcs.1401

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Cogn Sci        ISSN: 1939-5078


  31 in total

1.  The neural basis of motivational influences on cognitive control.

Authors:  Cameron Parro; Matthew L Dixon; Kalina Christoff
Journal:  Hum Brain Mapp       Date:  2018-08-18       Impact factor: 5.038

2.  Individual differences in baseline oculometrics: Examining variation in baseline pupil diameter, spontaneous eye blink rate, and fixation stability.

Authors:  Nash Unsworth; Matthew K Robison; Ashley L Miller
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

3.  Dopamine Modulates the Functional Organization of the Orbitofrontal Cortex.

Authors:  Thorsten Kahnt; Philippe N Tobler
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

4.  Adolescent cognitive control, theta oscillations, and social observation.

Authors:  George A Buzzell; Tyson V Barker; Sonya V Troller-Renfree; Edward M Bernat; Maureen E Bowers; Santiago Morales; Lindsay C Bowman; Heather A Henderson; Daniel S Pine; Nathan A Fox
Journal:  Neuroimage       Date:  2019-05-15       Impact factor: 6.556

5.  Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.

Authors:  Mareike Clos; Nico Bunzeck; Tobias Sommer
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

6.  Age-Related Differences in Motivational Integration and Cognitive Control.

Authors:  Debbie M Yee; Sarah Adams; Asad Beck; Todd S Braver
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

7.  Interactions of Motivation and Cognitive Control.

Authors:  Debbie M Yee; Todd S Braver
Journal:  Curr Opin Behav Sci       Date:  2017-11-24

8.  Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity.

Authors:  Lieke Hofmans; Danae Papadopetraki; Ruben van den Bosch; Jessica I Määttä; Monja I Froböse; Bram B Zandbelt; Andrew Westbrook; Robbert-Jan Verkes; Roshan Cools
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

9.  Catechol-O-methyltransferase (COMT) genotype affects cognitive control during total sleep deprivation.

Authors:  Brieann C Satterfield; John M Hinson; Paul Whitney; Michelle A Schmidt; Jonathan P Wisor; Hans P A Van Dongen
Journal:  Cortex       Date:  2017-11-26       Impact factor: 4.027

10.  Relationships Between Catecholamine Levels and Stress or Intelligence.

Authors:  Ye-Ha Jung; Joon Hwan Jang; Dasom Lee; Yoobin Choi; Soo-Hee Choi; Do-Hyung Kang
Journal:  Neurochem Res       Date:  2019-03-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.